Compare UnitedHealth Group Inc (UNH) vs Western Alliance Bancorporation (WAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
UnitedHealth Group Inc vs Western Alliance Bancorporation — how do they compare? UnitedHealth Group Inc trades at $398.88 (market cap $364.06B), while Western Alliance Bancorporation trades at $81.87 (market cap $9.01B). The key difference: UnitedHealth Group Inc is far larger — about 40.4× Western Alliance Bancorporation's market cap, and UnitedHealth Group Inc pays the higher dividend (2.29%). Which is the better fit depends on your goals.
| UNH | WAL | |
|---|---|---|
Market Cap | $364.06B | $9.01B |
Sector | Health | Financials |
52-Week High | $436.35 | $96.08 |
52-Week Low | $259.02 | $66.70 |
Enterprise Value | $405.92B | — |
Dividend Yield | 2.29% | 2.03% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
UnitedHealth Group (UNH) trades at $399.06, down 0.78% on the day, with a bearish technical signal but strong fundamental support from consistent earnings beats. The company reported Q2 2026 EPS of $6.38, beating expectations of $4.94, and maintains robust cash flow, funding dividends and buybacks. Recent news highlights strategic moves to reduce pediatric prior authorizations, aiming to improve care access and operational efficiency.
Outlook remains positive with an analyst consensus price target of $476.50, implying 19% upside, though regulatory risks from lawsuits and Medicaid fraud allegations pose challenges. The stock's valuation at a P/E of 26.07 is justified by its market leadership and growth in aging demographics, but investors should monitor legal developments and margin pressures.
Western Alliance Bancorporation (WAL) trades at $82.62, up 1.37% with strong analyst support (79% buy rating) and a $93.86 consensus price target. The stock shows bullish technical momentum above key support at $82, supported by positive earnings trends with two recent quarterly beats. Recent business developments include the launch of WA VenueX digital platform and multiple industry recognitions, while financials show stable revenue growth and attractive valuation metrics with P/E of 9.33.
WAL presents a compelling investment case with solid fundamentals, analyst optimism, and strategic innovation, though investors should monitor net cash flow volatility and institutional selling trends. The stock's current valuation below analyst targets suggests potential upside, balanced by banking sector sensitivity to interest rate changes and economic conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →About Western Alliance Bancorporation
Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.
Read more on WAL →
